Trials / Unknown
UnknownNCT02062216
Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- University of Roma La Sapienza · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess whether inflammatory receptors play a role in the pathogenesis of atherosclerosis.
Detailed description
Atherosclerosis is a chronic inflammatory disease characterized by lipid deposition and macrophages/foam cell accumulation beneath the arterial intima. Immune competent cells are abundant in atherosclerotic lesions, where they produce mainly proinflammatory cytokines. Macrophages play a central role in each stage of the pathogenesis of atherosclerosis. At the beginning, the so-called foam cells contribute to the formation of early lesions; in mature plaques, macrophages constitute 50% of the cells in the lesion; finally, they are involved in the mechanisms leading to plaque rupture. The primary objective of this study is to assess whether the inflammatory receptors play a role in the pathogenesis of atherosclerosis.
Conditions
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2017-12-01
- Completion
- 2018-12-01
- First posted
- 2014-02-13
- Last updated
- 2014-03-14
Source: ClinicalTrials.gov record NCT02062216. Inclusion in this directory is not an endorsement.